Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-17T20:14:34.875Z Has data issue: false hasContentIssue false

New Developments in Infection Control

Published online by Cambridge University Press:  02 January 2015

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Departments
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1981

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Selected Bibliography

Bernstein, DI, Ogra, PL. Fetomaternal aspects of immunization with RA 27/3 liveattenuated rubella virus vaccine during pregnancy. J Pediatr 1980;97:467–70.CrossRefGoogle Scholar
Buimovici-Klein, E, Hite, RL, Byrne, T, Cooper, LZ. Isolation of rubella viruses in milk after postpartum immunization. J Pediatr 1977:91:939-41.CrossRefGoogle ScholarPubMed
Cooper, LZ, Krugman, S. The rubella problem. DM 1969 Feb:3-38. CDC. Rubella—United States 1977-1980. MMWR 1980:29:378-80.Google Scholar
Farquhar, JD. Followup on rubella vaccinations and experience with subclinical reinfection. J Pediatr 1972;81:4605.CrossRefGoogle ScholarPubMed
Furukuwa, T, Miyata, T, Kondo, K, Kuno, K, Isomura, S, Takekoshi, T. Clinical trials of RA 27/3 (Wistar) rubella vaccine in Japan. Am J Dis Child 1969;118:2623.Google Scholar
Hayden, GF, Herrmann, KL, Buimovici-Klein, E, Weiss, KE, Nieberg, PL, Mitchell, JE. Subclinical congenital rubella infection associated with maternal rubella vaccination in early pregnancy. J Pediatr 1980;97:869–72.CrossRefGoogle Scholar
Herrmann, KL, Halstead, SB, Brandline-Bennett, AD, Witte, JJ, Wiebenga, XH, Eddins, DL. Rubella immunization persistence of antibody 4 years after a large-scale field trial. JAMA 1976:235:22014.CrossRefGoogle Scholar
Hillary, IB, Griffith, AH. Persistence of antibody 10 years after vacci nation with Wistar RA 27/3 strain live attenuated rubella vaccine. Br Med J 1980;224:15802.CrossRefGoogle Scholar
Horsimann, D. Controlling rubella: problems and perspective. Ann Intern Med 1975;83:4127.CrossRefGoogle Scholar
Klein, EB, Byrne, T, Cooper, LZ. Neonatal rubella in a breast-fed infant after postpartum maternal infection. J Pediatr 1980;97:7745.CrossRefGoogle Scholar
Krugman, S. Present status of measles and rubella immunization in the United States: a medical progress report. J Pediatr 1977;90:112.CrossRefGoogle ScholarPubMed
Landes, RD, Bass, JW, Millunchick, W, Oetgen, WJ. Neonatal rubella following postpartum maternal immunization. J Pediatr 1980;97:4657.CrossRefGoogle ScholarPubMed
Marymont, JH, Herrmann, KL. Rubella in pregnancy; review of current problems. Postgrad Med 1974;56:167–72.CrossRefGoogle ScholarPubMed
McLaughlin, MC, Gold, LH. The New York rubella incident: a case for changing hospital policy regarding rubel la testing and immunization. Am J Public Health 1979;69:2879.CrossRefGoogle Scholar
Polk, BF, White, JA, DeGirolami, PC, Modlin, JF. An outbreak of rubella among hospital personnel. N Engl J Med 1980;303:5415.CrossRefGoogle ScholarPubMed
Preblud, SR, Serdula, MK, Frank, JA, Brandling-Bennett, AD, Hin man, AR. Rubella vaccination in the United States: a ten-year review. Epidemiologic Reviews 1980;2:171–94.CrossRefGoogle ScholarPubMed
Weibel, RE, Buynak, EB, McLean, AA, Roehm, RR, Hilleman, MR. Persistence of antibody in human subjects 7 to 10 years fol lowing administration of combined live attenuated measles, mumps, and rubella virus vaccines. ProcSoc Exp Biol Med 1980;165:2603.CrossRefGoogle Scholar